Physician
Ramzi S Dakour MD and Ramona S Ataya Dakour MD, PLLC
Ramzi S Dakour MD and Ramona S Ataya Dakour MD, PLLC was paid $640K by Medicaid between Nov 2020 and Dec 2024, across 35 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoRAMZI S DAKOUR MD AND RAMONA S ATAYA DAKOUR MD, PLLC
BEAUMONT, TX 77701
BEAUMONT, TX 77701
33aNPI1851716385assigned 02/20/2014
33bProvider typeFamily Medicine Physician
28Total paid$640K
24GClaims24,543
24DCodes billed35
24AFirst – last monthNov 2020 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#139 of 1,204
Median peer was paid$31K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 132 | $4K | |
| 2021 | 963 | $31K | |
| 2022 | 2,852 | $74K | |
| 2023 | 11,006 | $264K | |
| 2024incomplete | 9,590 | $268K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 6,879 | 6,094 | $263K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 1,489 | 1,378 | $80K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 5,114 | 2,021 | $71K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 789 | 782 | $65K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 10% | 815 | 807 | $64K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.1% | 293 | 291 | $26K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.0% | 1,378 | 647 | $19K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.0% | 458 | 430 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 1,025 | 945 | $15K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 69 | 69 | $7K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 666 | 636 | $6K |
| 90461 | <1% | 2,133 | 602 | $2K |
23 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 110 | $1K |
| 99381 | <1% | 14 | $1K | |
| 96380 | <1% | 12 | $244.81 | |
| 87807 | <1% | 12 | $137.30 | |
| 96160 | <1% | 75 | $135.99 | |
| 90688 | <1% | 198 | $1.15 | |
| 90671 | <1% | 389 | $0.60 | |
| 90697 | <1% | 50 | $0.10 | |
| 90381 | <1% | 17 | $0.01 | |
| 90687 | 0% | 82 | $0.00 | |
| 90670 | 0% | 292 | $0.00 | |
| 90648 | 0% | 79 | $0.00 | |
| 99173 | 0% | 520 | $0.00 | |
| 90633 | 0% | 178 | $0.00 | |
| 90707 | 0% | 103 | $0.00 | |
| 90700 | 0% | 51 | $0.00 | |
| 90744 | 0% | 185 | $0.00 | |
| 90698 | 0% | 352 | $0.00 | |
| 90680 | 0% | 506 | $0.00 | |
| 90716 | 0% | 103 | $0.00 | |
| 96127 | 0% | 68 | $0.00 | |
| 90723 | 0% | 19 | $0.00 | |
| 90656 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAKOUR, RAMZI (PRESIDENT)